Assessment of Factors Affecting Symptom Control in Asthmatic Patients
DOI:
https://doi.org/10.36570/jduhs.2020.3.1028Keywords:
Asthma, Bronchial asthma, AntiasthmaticsAbstract
Objective: To assess the level of symptoms control achieved by Asthmatic Patients in Pakistan and the associated factors making an impact on symptom control.
Methods: A prospective cross-sectional study was carried out at Darul Sehat Hospital from December 2018 till December 2019. All patients of irrespective of age and gender diagnosed as bronchial asthma were consecutively included. Symptom control was assessed according to Global Initiative for Asthma (GINA) assessment tool. Prevalence of asthma symptom control was determined while association of risk factors with uncontrolled asthma was also evaluated.
Results: Of 113 patients the mean age was 36.8 +-16.6 years. There were 76 (67.3%) patients had uncontrolled asthma. A significant association of uncontrolled asthma was observed with incorrect inhaler technique (p value of 0.039) more than 10 years asthma duration (p value <0.001) lack of inhaled corticosteroid (ICS) use (p value 0.004) Gastroesophageal Reflux Disease (GERD) (p value <0.001) more than 1 episode of asthma exacerbation in last 12 months (p value <0.001) and with high use of short acting beta agonists (p value <0.001).
Conclusion: A higher prevalence of uncontrolled asthma was observed in our cohort with significant association of uncontrolled asthma with poor inhaler technique lack of ICS use GERD more than 10 years asthma duration and more than 1 asthma exacerbation episode in last 12 months.
Downloads
References
2. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of a s thma : executi ve summa r y of the GINA Dissemination Committee report. Allergy 2004; 59:469-78.doi: 10.1111/j.1398-9995.2004.00526.x.
3. Kang HR, Song HJ, Nam JH, Hong SH, Yang SY, Ju S, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open 2018 22; 8:e020825. doi: 10.1136/bmjopen-2017-020825.
4. Lin J, Wang W, Chen P, Zhou X, Wan H, Yin K, et al. Prevalence and risk factors of asthma in mainland China: The CARE study. Respir Med 2018; 137:48-54. doi: 10.1016/j.rmed.2018.02.010.
5. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: results from the American Productivity Audit. J Occup Environ Med 2003; 45:1234-46.doi: 10.1097/01.jom.0000099999.27348.78.
6. Gebremariam TH, Binegdie AB, Mitiku AS, Ashagrie AW, Gebrehiwot KG, Huluka DK, et al Level of asthma Rasheed et al. BMC Res Notes 2017; 10:558. doi: 10.1186/s13104-017-2887-z.
7. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med 2014; 24:14009. doi: 10.1038/npjpcrm.2014.9.
8. Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21:66-74. doi: 10.1183/09059180.00008111.
9. Mintz M, Gilsenan AW, Bui CL, Ziemiecki R, Stanford RH, Lincourt W, et al. Assessment of asthma control in primary care. Curr Med Res Opin 2009; 25:2523-31. doi: 10.1185/03007990903218655.
10. Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, et al. LIAISON Study Group. Determinants and impact of suboptimal asthma control in Europe: the international cross-sectional and longitudinal assessment on asthma control (LIAISON) study. Respir Res 2016; 17:51. doi: 10.1186/s12931-016-0374-z.
11. Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, et al. Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr 2016; 128(15-16):541-54. doi: 10.1007/s00508-016-1019-4.
12. Paasche-Orlow MK, Riekert KA, Bilderback A, Chanmugam A, Hill P, Rand CS, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med 2005; 172:980-6. doi: 10.1164/rccm.200409-1291OC.
13. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010 ; 36:995-1001. doi: 10.1183/09031936.00012610.
14. Gebremariam TH, Sherman CB, Schluger NW. Perception of asthma control among asthmatics seen inChest Clinic at Tertiary Hospital, Addis Ababa, Ethiopia. BMC Pulm Med 2019; 19:187. doi: 10.1186/s12890-019-0959-7.
15. Marchioro J, Gazzotti MR, Nascimento OA, Montealegre F, Fish J, Jardim JR. Level of asthma control and its relationship with medication use in asthma patients in Brazil. J Bras Pneumol 2014; 40:487-94. doi: 10.1590/s1806-37132014000500004.
16. Torchyan AA. Asthma control in Saudi Arabia: Gender implications. Allergy Asthma Proc 2017; 38:47-53. doi: 10.2500/aap.2017.38.4035.
17. Abrahamsen R, Gundersen GF, Svendsen MV, Klepaker G, Kongerud J, Fell AKM. Possible risk factors for poor asthma control assessed in a cross-sectional population-based study from Telemark, Norway. PLoS One 2020; 15:e0232621. doi: 10.1371/journal.pone.0232621.
18. Zein JG, Erzurum SC. Asthma is Different in Women. Curr Allergy Asthma Rep 2015 ; 15:28. doi: 10.1007/s11882-015-0528-y.
19. Haselkorn T, Szefler SJ, Simons FE, Zeiger RS, Mink DR, Chipps BE, et al. TENOR Study Group. Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR. Pediatr Allergy Immunol 2010; 21:1157-65. doi: 10.1111/j.1399-3038.2010.01065.x.
20. Bednarek A, Bodajko - Grochowska A, BartkowiakEmeryk M, Klepacz R, Ciolkowski J, Zarzycka D, et al. Demographic and medical factors affecting shortterm changes in subjective evaluation of asthma control in adolescents. Postepy Dermatol Alergol 2018 ; 35:259-66. doi: 10.5114/ada.2018.76221.
21. Hekking PP, Amelink M, Wener RR, Bouvy ML, Bel EH. Comorbidities in Difficult-to-Control Asthma. J Allergy Clin Immunol Pract 2018; 6:108-13. doi: 10.1016/j.jaip.2017.06.008.
22. Baffi CW, Wood L, Winnica D, Strollo PJ Jr, Gladwin MT, Que LG, et al. Metabolic syndrome and the lung. Chest 2016; 149:1525-34. doi: 10.1016/j.chest.2015.12.034.
23. Lin J, Gao J, Lai K, Zhou X, He B, Zhou J, et al. The characteristic of asthma control among nasal diseases population: Results from a cross-sectional study. PLoS One 2018 ; 13:e0191543. doi: 10.1371/journal.pone.0191543.
24. Agondi RC, Andrade MC, Takejima P, Aun MV, Kalil J, Giavina-Bianchi P. Atopy is associated with age at asthma onset in elderly patients. J Allergy Clin Immunol Pract 2018; 6):865-71. doi: 10.1016/j.jaip.2017.10.028.
25. Chogtu B, Holla S, Magazine R, Kamath A. Evaluation of relationship of inhaler technique with asthma control and quality of life. Indian J Pharmacol 2017; 49:110-5. doi: 10.4103/0253-7613.201012.
26. Harnett CM, Hunt EB, Bowen BR, O' Connell OJ, Edgeworth DM, Mitchell P, et al. A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic. J Asthma 2014; 51:440-5. doi: 10.3109/02770903.2013.876650.
27. Jaimchariyatam N, Wongtim S, Udompanich V, Sittipunt C, Kawkitinarong K, Chaiyakul S, et al. Prevalence of gastroesophageal reflux in Thai asthmatic patients. J Med Assoc Thai 2011; 94:671-8.
28. Tomisa G, Horváth A, Szalai Z, Müller V, Tamási L. Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study. J Asthma Allergy 2019; 12:297- 307. doi: 10.2147/JAA.S211246.
29. Albataineh E, Al-Zayadneh E, Al-Shagahin H, Soloman AA, Altarawneh A, Aldmour I. Asthma Control and Its Predictive Factors in Adult Asthma Patients. J Clin Med Res. 2019; 11:807-17.doi: 10.14740/jocmr4021.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Waqas Rasheed, Rashid Naseem Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. 
